Of the previously described SNP variants in pathways associated with HCC, only “growth hormone signaling pathway” was associated with steatosis (p(DS) value = 0.002, FDR odds ratio adjusted p-value<0.01). The gene discussed is GH1; the disease is hepatocellular carcinoma.